AstraBio (China) Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$7.42M
- Investors
-
13
AstraBio (China) General Information
Description
Manufacturer of in vitro diagnostics intended for patient healthcare optimization. The company utilizes enzyme-linked immunosorbent assay, polymerase chain reaction and microarray platforms to detect human hormones, genetic disorders, tumor markers and allergens, providing laboratories and biomedical partners with reagents and diagnostic kits to enable personalized medicine and individual patient therapy.
Contact Information
Website
www.astra-biotech.comCorporate Office
- Building 14, Liandong U Valley
- Number 200 Xingpu Road, Shengpu Town
- Suzhou, Jiangsu 215123
- China
Corporate Office
- Building 14, Liandong U Valley
- Number 200 Xingpu Road, Shengpu Town
- Suzhou, Jiangsu 215123
- China
AstraBio (China) Timeline
AstraBio (China) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B) | 31-Aug-2026 | $7.42M | Completed | Generating Revenue | ||
| 8. Secondary Transaction - Private | 13-Jul-2026 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 27-May-2024 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 13-Mar-2024 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 12-Jul-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 26-Mar-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 29-Jun-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 28-Jul-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 27-Sep-2020 | Completed | Generating Revenue |
AstraBio (China) Signals
AstraBio (China) Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Taizhou Jintai Private Equity Fund Management | Government | Minority | ||
| Univ-Bio | Corporation | Minority | ||
| LH Ventures (China) | PE/Buyout | Minority | ||
| Annoroad | VC-Backed Company | Minority | ||
| Zhengxuan Investment | Venture Capital | Minority |
AstraBio (China) Acquisitions (1)
AstraBio (China)’s most recent deal was a Merger/Acquisition with Renrui. The deal was made on 09-Oct-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Renrui | 09-Oct-2021 | Merger/Acquisition | Diagnostic Equipment |
AstraBio (China) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Renrui | Xiamen, China | 2012 |
AstraBio (China) FAQs
-
When was AstraBio (China) founded?
AstraBio (China) was founded in 2019.
-
Where is AstraBio (China) headquartered?
AstraBio (China) is headquartered in Suzhou, China.
-
What is the size of AstraBio (China)?
AstraBio (China) has 8 total employees.
-
What industry is AstraBio (China) in?
AstraBio (China)’s primary industry is Diagnostic Equipment.
-
Is AstraBio (China) a private or public company?
AstraBio (China) is a Private company.
-
What is AstraBio (China)’s current revenue?
The current revenue for AstraBio (China) is .
-
How much funding has AstraBio (China) raised over time?
AstraBio (China) has raised $22.3M.
-
Who are AstraBio (China)’s investors?
Taizhou Jintai Private Equity Fund Management, Univ-Bio, LH Ventures (China), Annoroad, and Zhengxuan Investment are 5 of 13 investors who have invested in AstraBio (China).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process